https://www.youtube.com/watch?v=wDq1-jOzVyA
Livongo Health, a company launched last year by Glen Tullman, a former CEO of Allscripts, has raised $20 million in a Series B round, according to an emailed statement from Tullman. The fresh capital will be used to support the young company’s development of its FDA-cleared blood glucose monitoring device and digital diabetes management program, Livongo for Diabetes for people with Type 1 and Type 2 diabetes.
Kleiner Perkins Caulfield and Byers led the round and Draper Fisher Jurvetson Venture and General Catalyst Partners participated. The funding will help the company build onto its chronic disease management platform and accelerate adoption of Livongo for Diabetes among payers, providers and employers, according to a separate statement on its website. As part of the agreement, KPCB General Partner Dr. Beth Seidenberg and Emily Melton, a partner at DFJ, will sit on Livongo’s board.
The company recently added payers to its customer base, which includes provider organizations like Mission Health, Healthcare Partners, and Cornerstone, and self-insured employers such as Iron Mountain, Office Depot, and Catamaran, among others, according to the statement.
In addition to these companies it also inked a multi-year strategic deal with electronic medical record provider and health IT vendor Cerner for integration and distribution to its client base, the statement said.
Since the company secured FDA clearance in September for its cellular-connected device to help diabetics manage their condition, it has built a base of more than 27,000 users with diabetes. The blood glucose meter also helps users automate tasks like transmitting data on their levels, activity and ordering testing strips.
In addition to automating tasks, its cloud receives data transmitted from the device, including activity levels, analyzes it using clinical rules and the user’s personal health history and sends users feedback on what to do next. The decision-making process gets smarter and more personalized the longer you participate in the program.
